TABLE 1.

Description of PMMoV genotypes used in this work

Genotype	CP gene profile		Capacity to infect the indicated hostc					Pathotyped
	Amino acid substitution(s)a	Nucleotide substitution(s)b	L1/L1	L2/L2	L3/L3	L4/L+	L4/L4
TS			+	+	NLL	NLL	NLL	P1,2
TS-(M138N)	M138N	T433A + G434T	+	+	+	NLL	NLL	P1,2,3
TS-(T43K+D50G)	T43K + D50G	C131A + A152G	+	+	+	+	NLL	P1,2,3
TS-(L13F+G66V)	L13F + G66V	A42T + G200T	+	+	+	NLL	NLL	P1,2,3
MG			+	+	NLL	NLL	NLL	P1,2
MG-(M138N)	M138N	T433A + G434T	+	+	+	NLL	NLL	P1,2,3
MG-(T43K+D50G)	T43K + D50G	C131A + A152G	+	+	+	+	NLL	P1,2,3
MG-(A87G)	A87G	G260C	+	+	+	+	+	P1,2,3,4

^aChange of amino acid in the CP from parental TS or MG genotype (pathotype P_1,2).

^bChange of nucleotide in the CP gene from parental TS or MG genotype (pathotype P_1,2).

^cNLL, necrotic local lesions; +, infection present.

^dPathotype of the parental and mutant genotypes.